IN8bio, Inc.INABNASDAQ
LOADING
|||
Cash Flow Under Pressure
Below historical average, strong compound growth.
Left:
|
|
|
|

Operating cash flow minus capital expenditures

Latest
$-24.25M
↓ 61% below average
Average (6y)
$-15.09M
Historical baseline
Range
High:$-3.53M
Low:$-27.83M
CAGR
+37.9%
Consistent expansion
PeriodValueChange
2024$-24.25M-1.3%
2023$-23.94M+14.0%
2022$-27.83M-101.4%
2021$-13.82M-93.7%
2020$-7.13M-39.0%
2019$-5.13M-45.5%
2018$-3.53M-